Ondansetron prevents chemotherapy-induced vomiting by blocking which receptor in the gastrointestinal tract and the chemoreceptor trigger zone?
- A Dopamine D2 receptors
- B Histamine H1 receptors
- C 5-HT3 (serotonin type 3) receptors ✓
- D Muscarinic M1 receptors
Explanation
Cytotoxic drugs trigger release of serotonin (5-HT) from enterochromaffin cells of the gut mucosa, which activates vagal afferents via 5-HT3 receptors, stimulating the vomiting centre. 5-HT3 receptors are also present in the chemoreceptor trigger zone (area postrema). Ondansetron, a selective 5-HT3 antagonist, blocks both peripheral vagal and central pathways of emesis, making it particularly effective for acute chemotherapy-induced and radiotherapy-induced nausea and vomiting.
Reference: KD Tripathi, Essentials of Medical Pharmacology, 8th ed.
High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP
Written and medically reviewed by the StethoPrep medical team.